Vinay Prasad geeft een korte samenvatting van een nieuwe paper in Nature Medicine over het risico van myocarditis als gevolg van vaccinatie. Mannen onder 40 en vooral jongens tussen 16 en 24 hebben een verhoogd risico
It is now clear for men <40, dose two and dose three of Pfizer have more myocarditis than sars-cov-2 infection, and this is true for dose one and dose two of Moderna.
Pfizer boosters (Dose three) have more myocarditis for men <40 than infection.
Myocarditis post infection is more common as you get older, in contrast with myocarditis post vaccination, which is more common as you are younger (reverse gradients)
But the truth is STILL WORSE than these data.
If the authors fixed the denominator for viral infection (i.e. used sero-prevalance), it would look even worse
If the authors separate men 16-24 from 12-15 and 25-40, it would likely look worst in 16-24 age group.
留言